C2 Blockchain Authorizes Massive Share Increase, Paving Way for Significant Future Dilution
summarizeSummary
C2 Blockchain, Inc. amended its charter to authorize a massive increase in common and preferred stock, enabling significant future capital raises but signaling extreme potential dilution for current shareholders.
check_boxKey Events
-
Authorized Capital Stock Increased
The company filed Amended and Restated Articles of Incorporation, increasing its authorized capital stock to an aggregate of 1,520,000,000 shares, consisting of 1,500,000,000 shares of common stock and 20,000,000 shares of preferred stock.
-
Series A Preferred Stock Designated
Of the authorized preferred stock, 5,000,000 shares have been designated as Series A Preferred Stock, each entitled to 100 votes per share and convertible into 100 shares of common stock, subject to availability.
-
Enables Future Dilutive Financing
This authorization provides the company with the capacity to issue a substantial number of shares, which is a necessary step for capital raising, especially in light of the company's previously disclosed 'going concern' warning and recent discounted stock sales.
auto_awesomeAnalysis
C2 Blockchain, Inc. has significantly increased its authorized capital stock, a critical step for a company previously disclosing substantial doubt about its ability to continue as a going concern. This authorization, particularly the 1.5 billion common shares and 5 million Series A Preferred shares convertible into 500 million common shares, provides the company with the necessary headroom to raise substantial capital. However, given the company's current market capitalization, the potential issuance of these shares represents an extremely high level of future dilution for existing shareholders. This follows a recent pattern of discounted stock sales, indicating an ongoing need for capital to sustain operations.
At the time of this filing, CBLO was trading at $0.13 on OTC in the Crypto Assets sector, with a market capitalization of approximately $59.7M. The 52-week trading range was $0.01 to $0.30. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.